This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Innovations of Joan E Johnson
Introduction
Joan E Johnson is a notable inventor based in Libertyville, IL (US). She has made significant contributions to the field of medical research, particularly in the detection of specific viruses. Her work has implications for understanding and diagnosing conditions related to human T-cell lymphotropic virus type II (HTLV-II).
Latest Patents
Joan E Johnson holds a patent for "Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides." This invention relates to a novel human T-cell lymphotropic virus type II isolate designated NRA. HTLV-II was originally isolated from a patient with atypical hairy cell leukemia. Preliminary restriction analysis of this isolate demonstrated that it differs genetically from the prototypical HTLV-II isolate Mo. The claimed invention is particularly directed toward the gp46 and p21 envelope proteins encoded by the env gene. Methods and kits for the detection of HTLV-II antibodies employing these envelope proteins are also described. She has 1 patent to her name.
Career Highlights
Joan E Johnson has had a distinguished career, working at Abbott Laboratories Corporation. Her role at this prominent company has allowed her to engage in groundbreaking research and development in the medical field.
Collaborations
Throughout her career, Joan has collaborated with esteemed colleagues, including Emerson W Chan and Helen H Lee. These partnerships have contributed to her innovative work and advancements in her field.
Conclusion
Joan E Johnson's contributions to medical research and her innovative patent highlight her role as a significant inventor in the field. Her work continues to impact the understanding and detection of important viral infections.